Treats pruritic skin. Sold as Eurax. Every FDA application for this active ingredient: 2 branded and 1 generic.
As of Nov 16, 2026, FDA lists 3 applications for Crotamiton (sold as Eurax), first approved Jul 6, 1949, with 0 new uses approved and 0 published complete response letters.
| Crotan | Part D | $2.9M | -25% | 895 |
| Pruradik | Part D | $234K | New | 88 |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA